| Trial ID: | L5675 |
| Source ID: | NCT02026232
|
| Associated Drug: |
Hydroxychloroquine
|
| Title: |
Metabolic Effects of Hydroxychloroquine
|
| Acronym: |
MetaHcQ
|
| Status: |
TERMINATED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02026232/results
|
| Conditions: |
Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Hydroxychloroquine|OTHER: Hydroxychloroquine Placebo
|
| Outcome Measures: |
Primary: Effect of HCQ on Fasting Blood Glucose, determined by fasting blood glucose performed at baseline and follow-up, 4 weeks | Secondary: Effect of HCQ on Fasting Low Density Lipoprotein, determined by lipid profile with calculated LDL performed at baseline and follow-up, 4 weeks
|
| Sponsor/Collaborators: |
Sponsor: Washington University School of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
21
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: OTHER
|
| Start Date: |
2012-03
|
| Completion Date: |
2022-12-15
|
| Results First Posted: |
2023-12-28
|
| Last Update Posted: |
2023-12-28
|
| Locations: |
Washington University, Saint Louis, Missouri, 63110, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02026232
|
